{"casebody": {"status": "ok", "data": "<html><body><casebody firstpage=\"852\" lastpage=\"852\" xmlns=\"http://nrs.harvard.edu/urn-3:HLS.Libr.US_Case_Law.Schema.Case_Body:v1\">\n<parties id=\"p-1\">STETSER<br/> v.<br/> TAP PHARMACEUTICAL PROD.</parties>\n<docketnumber id=\"p-2\">No. 142PA04.</docketnumber>\n<court id=\"p-3\">Supreme Court of North Carolina.</court>\n<decisiondate id=\"p-4\">March 3, 2005.</decisiondate>\n<attorneys id=\"p-5\">Marvin K. Blount, Jr., Marvin K. Blount, III, Greenville, Donald E. Haviland, Jr., TerriAnne Benedetto, Kent Williams, Jonathan Shub, Philadelphia, PA., for Stetser et al.</attorneys>\n<attorneys id=\"p-6\">Matthew W. Sawchak, Raleigh, for Takeda Chemical Industries, Ltd.</attorneys>\n\n\n<opinion type=\"majority\"><p id=\"p-7\">The following order has been entered on the motion filed on the 28th day of February 2005 by Defendant (Takeda Pharmaceutical Co.) to Seal Selected Portion of Defendant Appellee's Brief:</p><p id=\"p-8\">\"Motion Allowed by order of the Court in conference this the 3rd day of March 2005.\"</p></opinion>\n</casebody></body></html>"}}